Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Nutr Cancer ; 63(7): 1029-35, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21875326

RESUMEN

The aberrant crypt foci (ACF), cyclooxygenase 2 (COX-2), and the proliferating cell nuclear antigen (PCNA) are putative biomarkers for colon cancer. To study the association between light (1 g of ethanol/kg bw) and moderate (3 g of ethanol/kg bw) doses of ethanol with the chemical carcinogen N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), Wistar rats were divided into 6 groups. The colon fragments were collected for histochemical and immunohistochemical analyses, and the liver samples were collected for oxidative stress analysis, with products of lipid peroxidation (malondialdehyde), antioxidant enzymes (glutathione), and vitamin E. The association of light and moderate doses of ethanol with MNNG did not present differences in the oxidative parameters. However, a reduction in vitamin E levels in the carcinogen groups was observed. The association induced a reduction of the COX-2 and PCNA expression. The number of ACF in the group that received a light dose of ethanol had lower rates, while the group that received a moderate dose had the highest rates compared to the control MNNG, demonstrating that the light dose of ethanol could have a protective effect, while the moderate dose could represent a risk during chemical carcinogenesis in rats.


Asunto(s)
Carcinógenos/toxicidad , Colon/efectos de los fármacos , Neoplasias del Colon/inducido químicamente , Relación Dosis-Respuesta a Droga , Etanol/administración & dosificación , Etanol/toxicidad , Focos de Criptas Aberrantes/patología , Animales , Antioxidantes/análisis , Biomarcadores/análisis , Colon/patología , Ciclooxigenasa 2/genética , Ciclooxigenasa 2/metabolismo , Glutatión/análisis , Inmunohistoquímica , Peroxidación de Lípido , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Malondialdehído/análisis , Metilnitronitrosoguanidina/toxicidad , Estrés Oxidativo , Antígeno Nuclear de Célula en Proliferación/genética , Antígeno Nuclear de Célula en Proliferación/metabolismo , Ratas , Ratas Wistar , Vitamina E/análisis
2.
J Am Soc Hypertens ; 11(1): 10-19, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27876342

RESUMEN

Association between hypertriglyceridemia and cardiovascular (CV) disease is still controversial. The purpose of this study was to compare omega-3 and ciprofibrate effects on the vascular structure and function in low and high CV risk hypertensive patients with hypertriglyceridemia. Twenty-nine adults with triglycerides 150-499 mg/dL were divided into low (<7.5%) and high (≥7.5%) CV risk, randomized to receive omega-3 fatty acids 1800 mg/d or ciprofibrate 100 mg/d for 12 weeks. Treatment was switched after 8-week washout. Clinical evaluation and vascular tests were assessed at baseline and after intervention. Peripheral (131 ± 3 to 125 ± 3 mm Hg, P < .05) and aortic (124 ± 3 to 118 ± 2 mg/dL, P < .05) systolic blood pressure were decreased by ciprofibrate in low-risk patients. In high-risk patients, pulse wave velocity was reduced (10.4 ± 0.4 to 9.4 ± 0.3 m/s, P < .05) and flow-mediated dilation was increased (11.1 ± 1.6 to 13.5 ± 1.2%, P < .05) by omega-3. In conclusion, omega-3 improved arterial stiffness and endothelial function, pointing out the beneficial effect of this therapy on vascular aging, in high-risk patients.


Asunto(s)
Enfermedades Cardiovasculares/prevención & control , Endotelio Vascular/efectos de los fármacos , Ácidos Grasos Omega-3/administración & dosificación , Ácidos Fíbricos/administración & dosificación , Hipertensión/tratamiento farmacológico , Hipertrigliceridemia/tratamiento farmacológico , Rigidez Vascular/efectos de los fármacos , Adulto , Enfermedades Cardiovasculares/epidemiología , Endotelio Vascular/fisiopatología , Femenino , Humanos , Hipertensión/diagnóstico , Hipertensión/fisiopatología , Hipertrigliceridemia/diagnóstico , Hipertrigliceridemia/fisiopatología , Hipolipemiantes/administración & dosificación , Masculino , Persona de Mediana Edad , Análisis de la Onda del Pulso/métodos , Factores de Riesgo , Resultado del Tratamiento
3.
Nutrients ; 6(8): 3214-29, 2014 Aug 13.
Artículo en Inglés | MEDLINE | ID: mdl-25123248

RESUMEN

This work investigated the effects of Vitamin E (VE) on aberrant crypt foci (ACF) incidence, oxidative stress parameters (serum and hepatic VE concentration, and homocysteine, glutathione (GSH), and malondialdehyde (MDA) levels), and expression of both cyclooxygenase-2 (COX2) and proliferating cellular nuclear antigen (PCNA) in experimental colorectal carcinogenesis. Male Wistar rats received subcutaneous injections of 1,2-dimethylhydrazine (DMH) twice a week, for two weeks (40 mg/kg), except for the Control group. Animals were separated into groups that received different amounts of VE in the diet: 0 IU (0×), 75 IU (recommended daily intake, RDI), 225 IU (3× RDI), or 1500 IU (20× RDI), during (dDMH) or after (aDMH) administration of carcinogen. The 0×dDMH and 3×dDMH groups showed decreased serum VE levels. Hepatic VE concentration was higher in 3×aDMH as compared with the other groups. All the groups, except the Control and the 0×aDMH groups, had reduced GSH levels. The 0×dDMH, 0×aDMH, and 20×aDMH groups exhibited increased MDA levels. The aDMH groups had higher ACF incidence and PCNA expression. The 0×aDMH group presented higher ACF rate, followed by 20×aDMH. Moreover, the 3×aDMH group displayed reduced ACF incidence and COX2 expression. Multivariate analysis revealed that GSH modulated homocysteine levels and COX2. These results suggested that 1500 IU of VE is hazardous, whereas 225 IU of VE has beneficial effects on chemical colorectal carcinogenesis.


Asunto(s)
Carcinogénesis/efectos de los fármacos , Neoplasias Colorrectales/tratamiento farmacológico , Suplementos Dietéticos , Vitamina E/farmacología , 1,2-Dimetilhidrazina/administración & dosificación , 1,2-Dimetilhidrazina/toxicidad , Focos de Criptas Aberrantes/tratamiento farmacológico , Animales , Biomarcadores/sangre , Carcinógenos/administración & dosificación , Carcinógenos/toxicidad , Proliferación Celular/efectos de los fármacos , Neoplasias Colorrectales/inducido químicamente , Ciclooxigenasa 2/genética , Ciclooxigenasa 2/metabolismo , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Regulación Neoplásica de la Expresión Génica , Glutatión/sangre , Homocisteína/sangre , Inmunohistoquímica , Masculino , Análisis Multivariante , Estrés Oxidativo/efectos de los fármacos , Antígeno Nuclear de Célula en Proliferación/genética , Antígeno Nuclear de Célula en Proliferación/metabolismo , Ratas , Ratas Wistar , Ingesta Diaria Recomendada , Aumento de Peso/efectos de los fármacos
4.
Rev. SOCERJ ; 21(4): 205-211, jul.-ago. 2008. tab, graf
Artículo en Portugués | LILACS | ID: lil-500175

RESUMEN

Fundamentos: É indispensável o conhecimento dos principais fatores de risco que contribuem para o surgimento da síndrome metabólica(SM), destacando-se a composição do plano alimentar. Objetivo: Analisar o consumo alimentar, quantitativo e qualitativo, de hipertensos com e sem SM atendidos em um hospital universitário. Métodos: Noventa e quatro pacientes hipertensos foram sequencialmente selecionados e estratificados em dois grupos , conforme a presença ou não de SM , de acordo com os critérios preconizados pela I Diretriz Brasileira para SM. Foram avaliados parâmetros clínicos, antropométricos, nutricionais e laboratoriais. Resultados: Os grupos foram homogênios em relação à idade (58,1 +- 9,8 vs 57,6 +- 8,7 anos). O grupo com SM (n=60) apresentou média da pressão arterial diastólica significativamente maior (94,7 +-8,7mmHg vs 90,6 +- 9,7mmHg, p >0,05) em relação ao grupo sem SM (n=34). A recomendação quantitativa para macronutrientes foi atingida, porém a qualitataiva apresentou excessos importantes...


Asunto(s)
Humanos , Masculino , Femenino , Persona de Mediana Edad , Hipertensión/complicaciones , Hipertensión/diagnóstico , Evaluación Nutricional , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA